CLEC11A improves insulin secretion and promotes cell proliferation in human beta-cells.
Ontology highlight
ABSTRACT: Beta-cell dysfunction is a hallmark of disease progression in patients with diabetes. Research has been focused on maintaining and restoring beta-cell function during diabetes development. The aims of this study were to explore the expression of C-type lectin domain containing 11A (CLEC11A), a secreted sulphated glycoprotein, in human islets and to evaluate the effects of CLEC11A on beta-cell function and proliferation in vitro. To test these hypotheses, human islets and human EndoC-βH1 cell line were used in this study. We identified that CLEC11A was expressed in beta-cells and alpha-cells in human islets but not in EndoC-βH1 cells, whereas the receptor of CLEC11A called integrin subunit alpha 11 was found in both human islets and EndoC-βH1 cells. Long-term treatment with exogenous recomb
SUBMITTER: Shi R
PROVIDER: S-EPMC10326638 | biostudies-literature | 2023 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA